DavidJInwardsMD
Hematology • Rochester, MNAssociate Professor, Internal Medicine, Mayo Medical School
Dr. Inwards is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1990 - 1991
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1988 - 1990
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1987
Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986- Mayo Clinic College of MedicineClass of 1984
Certifications & Licensure
MN State Medical License 1988 - 2024
IA State Medical License 1988 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Cladribine in Patients With Mantle Cell Lymphoma Start of enrollment: 1996 Nov 01
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Start of enrollment: 2003 Feb 01
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsPredicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.Sutapa Sinha, Dennis A. Gastineau, Ivana N. Micallef, William J. Hogan, S. M. Ansell
Bone Marrow Transplantation. 2011-07-01 - 268 citationsComparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.Koen van Besien, Fausto R. Loberiza, Ruta Bajorunaite, James O. Armitage, Asad Bashey
Blood. 2003-11-15 - 85 citationsInfused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopo...Luis F. Porrata, Mark R. Litzow, David J. Inwards, Dennis A. Gastineau, S. B. Moore
Bone Marrow Transplantation. 2004-02-01
Journal Articles
- Primary Systemic Amyloidosis in Patients with Waldenström MacroglobulinemiaAngela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
Abstracts/Posters
- Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?David J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment EraDavid J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell LymphomaDavid James J Inwards, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
